TORNTPHARM.NSTORNTPHARM.NS
LOADING
|||
Price to Sales: Premium Valuation
Trending higher, above historical average, strong compound growth.
Left:
||||
Price-to-sales ratio
Latest
9.36
↑ 73% above average
Average (9y)
5.41
Historical baseline
Range
High:9.36
Low:3.40
CAGR
+11.9%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2025 | 9.36 | +10.9% |
| 2024 | 8.44 | +56.1% |
| 2023 | 5.41 | -2.6% |
| 2022 | 5.55 | +3.2% |
| 2021 | 5.38 | +28.0% |
| 2020 | 4.20 | +0.3% |
| 2019 | 4.19 | +16.3% |
| 2018 | 3.60 | -20.3% |
| 2017 | 4.52 | +32.8% |
| 2016 | 3.40 | - |